TWO SIGMA ADVISERS, LP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 160 filers reported holding PTC THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,574,822
-60.7%
204,142
-28.7%
0.01%
-60.0%
Q2 2023$11,649,596
-26.8%
286,442
-12.8%
0.03%
-26.8%
Q1 2023$15,919,418
+30.8%
328,642
+3.0%
0.04%
+20.6%
Q4 2022$12,174,016
-11.2%
318,942
+16.8%
0.03%
-15.0%
Q3 2022$13,707,000
+6158.9%
273,042
+4864.4%
0.04%
+3900.0%
Q4 2021$219,000
-48.7%
5,500
-21.4%
0.00%0.0%
Q4 2020$427,000
-81.1%
7,000
-85.5%
0.00%
-83.3%
Q3 2020$2,263,000
-83.0%
48,400
-81.5%
0.01%
-84.6%
Q2 2020$13,306,000
-2.6%
262,242
-14.3%
0.04%
-25.0%
Q1 2020$13,657,000
+7.4%
306,142
+15.6%
0.05%
+73.3%
Q4 2019$12,716,000
+3662.1%
264,742
+3429.9%
0.03%
+2900.0%
Q2 2019$338,000
-83.9%
7,500
-86.6%
0.00%
-80.0%
Q1 2019$2,100,000
-8.8%
55,800
-16.8%
0.01%
-16.7%
Q4 2018$2,303,000
-70.8%
67,100
-60.0%
0.01%
-68.4%
Q3 2018$7,882,000
-40.1%
167,700
-57.0%
0.02%
-45.7%
Q2 2018$13,161,000
+43.2%
390,200
+14.9%
0.04%
+40.0%
Q1 2018$9,190,000
+712.6%
339,600
+110.8%
0.02%
+316.7%
Q2 2016$1,131,000
-22.2%
161,100
-28.7%
0.01%
-25.0%
Q1 2016$1,454,000
+372.1%
225,800
+3428.1%
0.01%
+300.0%
Q2 2015$308,000
-64.4%
6,400
-54.9%
0.00%
-71.4%
Q1 2015$864,000
+233.6%
14,200
+184.0%
0.01%
+250.0%
Q4 2014$259,0005,0000.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders